supp.fit

Prebiotics: study protocols

247 study groups say how much Prebiotics participants took a day. These are the doses the studies gave. They are not a recommendation.

Prebiotics: what the research found →

Dose per serving from products

457 products in our catalogue print how much Prebiotics a serving holds.

Most common: 500 mg to 1 g, 28% of 457 products.

Dose per servingProducts
10 mg or less
12
10 mg to 25 mg
32
25 mg to 50 mg
51
50 mg to 100 mg
42
100 mg to 250 mg
44
250 mg to 500 mg
23
500 mg to 1 g
128
1 g to 2.5 g
40
2.5 g to 5 g
65
over 5 g
20

Dose per serving from research

247 study groups in 193 studies say how much Prebiotics participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 g to 10 g, 32% of 247 study groups.

Daily doseStudy groups
100 mg or less
10
100 mg to 250 mg
6
250 mg to 500 mg
11
500 mg to 1 g
8
1 g to 2.5 g
28
2.5 g to 5 g
45
5 g to 10 g
78
10 g to 25 g
47
25 g to 50 g
11
over 50 g
3

Commonly used together

97 of 247 study groups took Prebiotics with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Probiotics
69
Iron
6
Inulin
4
Zinc
4
Vitamin D
3
Yacon
3

247 study groups

Study
Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial
2014 · prebiotic group · Preterm infants born at 32+0 to 36+6 weeks' gestation, recruited on days 1–3 of life
600 mg60 days23
Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot Study
2024 · 1-kestose administration group · Adults aged 20–80 with untreated, unresectable pancreatic ductal adenocarcinoma receiving chemotherapy
9 g12 weeks20
Effects of Bifidobacterium lactis HN019 and prebiotic oligosaccharide added to milk on iron status, anemia, and growth among children 1 to 4 years old
2010 · probiotic- and prebiotic-fortified milk · Children aged 1 to 4 years in a periurban community
2.4 g1 year312
Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial
2010 · Prebiotic and probiotic fortified milk (PP) · Children aged 1–4 years in a community setting in India, with no specific diagnosed condition required
2.4 g1 year312
Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial
2018 · Synbiotics group · Patients older than 16 years with sepsis requiring mechanical ventilation in the ICU
10 g20 days35
Exploring the synergistic effects of vitamin D and synbiotics on cytokines profile, and treatment response in breast cancer: a pilot randomized clinical trial
2024 · Synbiotic group (Pro) · Adult women with histologically confirmed, non-metastatic primary invasive breast cancer who were candidates for neoadjuvant therapy
38.5 mg18 weeks21
Exploring the synergistic effects of vitamin D and synbiotics on cytokines profile, and treatment response in breast cancer: a pilot randomized clinical trial
2024 · Vitamin D + synbiotic group (VitD + Pro) · Adult women with histologically confirmed, non-metastatic primary invasive breast cancer who were candidates for neoadjuvant therapy
38.5 mg18 weeks18
Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial
2008 · synbiotic group · Newborn infants at high risk for allergy
800 mg26 weeks—
Follow-up formula consumption in 3- to 4-year-olds and respiratory infections: an RCT
2014 · FUF group · Healthy children aged 3–4 years
3.6 g28 weeks—
Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants
2017 · FeGOS group · Kenyan infants aged 6.5–9.5 months
7.5 g120 days—
Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence
2018 · B-GOS® treatment · Adults from the general population with gastrointestinal symptoms and a predicted probability of functional bowel disorder greater than 75%
2.75 g2 weeks83
Effects of Yeast Mannan Which Promotes Beneficial Bacteroides on the Intestinal Environment and Skin Condition: A Randomized, Double-Blind, Placebo-Controlled Study
2020 · YM group · Healthy women aged 30–49 years who were aware of skin dryness and had stable menstrual periods
1.1 g8 weeks55
Prebiotic effect of two grams of lactulose in healthy Japanese women: a randomised, double-blind, placebo-controlled crossover trial
2019 · lactulose · Healthy Japanese women with defaecation frequency of 2–4 times per week
2 g2 weeks52
Prebiotics improve frailty status in community-dwelling older individuals in a double-blind, randomized, controlled trial
2024 · Prefrail prebiotic intervention group · Community-dwelling men and women over 65 years old who were prefrail
15 g12 weeks50
Prebiotics improve frailty status in community-dwelling older individuals in a double-blind, randomized, controlled trial
2024 · Frail prebiotic intervention group · Community-dwelling men and women over 65 years old who were frail
15 g12 weeks50
Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial
2022 · 5.5 g GOS · Adults aged 18–56 with self-reported constipation
5.5 g3 weeks45
Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial
2022 · 11 g GOS · Adults aged 18–56 with self-reported constipation
11 g3 weeks44
Effect of oral administration of Triphala, a polyphenol-rich prebiotic, on scalp sebum in patients with scalp seborrhea a randomized clinical trial
2022 · Triphala group · Participants aged 14–50 years with scalp seborrhea
2 g8 weeks40
Improvement of sleep by resistant dextrin prebiotic in type 2 diabetic women coincides with attenuation of metabolic endotoxemia: involvement of gut-brain axis
2022 · intervention group · Obese women with type 2 diabetes
10 g8 weeks38
Impact of dietary supplementation with resistant dextrin (NUTRIOSE(®)) on satiety, glycaemia, and related endpoints, in healthy adults
2021 · resistant dextrin (RD) treatment · Healthy adults aged 22–55 years, normal weight or overweight
14 g4 weeks36
Effectiveness of Partially Hydrolyzed Guar Gum on Cognitive Function and Sleep Efficiency in Healthy Elderly Subjects in a Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Study
2024 · PHGG group (test food group) · Healthy Japanese men and women aged over 60 years, with MMSE-J score of at least 24 and relatively low gait speed
5 g12 weeks30
Indicators of improved emotion behavior in 6-14-year-old children following a 4-week placebo controlled prebiotic supplement intervention at home with a parent
2025 · GOS group · Healthy children aged 6–14 years without current clinical anxiety, psychological diagnoses, developmental disorders, gastrointestinal problems or restrictive diets; girls and boys
5.5 g4 weeks28
The Effects of Agave Fructans in a Functional Food Consumed by Patients with Irritable Bowel Syndrome with Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial
2023 · experimental group · Adults, average age 50 years, mostly women, with constipation-predominant irritable bowel syndrome
7.8 g30 days25
Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit
2020 · AXOS · Healthy men and women aged 20–55 years with slow gastrointestinal transit and no constipation
15 g12 weeks24
β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria
2020 · LFD/B-GOS · Adults with Rome III irritable bowel syndrome recruited from secondary care in the United Kingdom
1.4 g4 weeks24
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome
2023 · LFD/B-GOS · Adults meeting Rome III criteria for irritable bowel syndrome
1.8 g4 weeks24
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study
2025 · 2FL + placebo · Adults aged 18–90 with a diagnosed primary Parkinsonian syndrome and moderate disease severity
3.9 g26 weeks23
A Double-Blind Randomised Controlled Trial of Prebiotic Supplementation in Children with Autism: Effects on Parental Quality of Life, Child Behaviour, Gastrointestinal Symptoms, and the Microbiome
2025 · GOS (prebiotic) group · Children aged 4–10 years with an existing diagnosis of autism; sex not restricted
2.4 g6 weeks22
Agave tequilana Fructans Versus Psyllium plantago for Functional Constipation : Randomized Double-blind Clinical Trial
2024 · Group 1: AF 5 g (Predilife) · Adults with functional constipation; age and sex range not reported
5 g8 weeks21
Effects of Human Milk Oligosaccharide 2'-Fucosyllactose Ingestion on Weight Loss and Markers of Health
2024 · 2′-FL group · Men and women aged 18–65 with overweight or obesity (BMI 25–40 kg/m² and/or body fat above 30%), beginning a weight-loss and walking program
3 g12 weeks21
Effect of a prebiotic mixture on intestinal comfort and general wellbeing in health
2008 · FOS · Healthy volunteers aged 20–37 years, male and female
10 g5 weeks20
Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study
2010 · AXOS · Healthy adults; age and sex not reported
10 g3 weeks20
Effects of Prebiotic Yeast Mannan on Gut Health and Sleep Quality in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study
2023 · YM group · Healthy Japanese adults aged 20–64 with discomfort in defecation
1.1 g4 weeks20
A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects
2018 · Oligofructose · Healthy adults aged 18 years or older; both sexes; no stated gastrointestinal disorder
14 g7 days19
A prebiotic galactooligosaccharide mixture reduces severity of hyperpnoea-induced bronchoconstriction and markers of airway inflammation
2016 · B-GOS · Adults with asthma and hyperpnoea-induced bronchoconstriction, and control adults without asthma; age and sex not reported
5.5 g3 weeks18
Agave tequilana Fructans Versus Psyllium plantago for Functional Constipation : Randomized Double-blind Clinical Trial
2024 · Group 2: AF 10 g (Predilife) · Adults with functional constipation; age and sex range not reported
10 g8 weeks18
Daily consumption of galactooligosaccharide gummies ameliorates constipation symptoms, gut dysbiosis, degree of depression and quality of life among sedentary university teaching staff: A double-blind randomized placebo control clinical trial
2023 · experimental group · Sedentary adults with functional constipation; age range and sex not stated
10 g30 days17
Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men
2006 · 30 g NUTRIOSE FB group · Healthy men; age and BMI reported for the study group as a whole, not by arm
30 g5 weeks16
Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men
2006 · 45 g NUTRIOSE FB group · Healthy men; age and BMI reported for the study group as a whole, not by arm
45 g5 weeks16
Comparison of the Effects of Prebiotics and Synbiotics Supplementation on the Immune Function of Male University Football Players
2023 · prebiotic group (PG) · Male university football players; age not reported; healthy student-athletes undergoing high-intensity training
2 g6 weeks15
The effect of arabinoxylooligosaccharides on gastric sensory-motor function and nutrient tolerance in man
2016 · AXOS · Healthy volunteers, 32.2 ± 1.8 years, 6 male; no stated condition
37.6 g2 days13
A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of 1-Kestose on Defecation Habits in Constipated Kindergarten Children: A Pilot Study
2023 · kestose group · Kindergarten children with defecation on 4 or fewer days per week
3 g8 weeks11
Effects of polydextrose supplementation on different faecal parameters in healthy volunteers
2009 · polydextrose supplementation · Healthy subjects; age and sex not reported
8 g——
Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students
2011 · 2.5 g galactooligosaccharides · Undergraduate students experiencing academic exam stress; age and sex not specified
2.5 g8 weeks—
Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students
2011 · 5.0 g galactooligosaccharides · Undergraduate students experiencing academic exam stress; age and sex not specified
5 g8 weeks—
Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study
2014 · XOS · Healthy adults aged 25–65 years
8 g3 weeks—
Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial
2016 · LU · Adults aged 18–65 with overweight or obesity (BMI 28.0–34.9)
12 g26 weeks—
Randomized Controlled Trial on the Effect of Partially Hydrolyzed Guar Gum Supplementation on Diarrhea Frequency and Gut Microbiome Count Among Pelvic Radiation Patients
2021 · Intervention group (IG) · Adults undergoing pelvic radiation for pelvic cancers
20 g4 weeks—
Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial
2021 · FOS group · Adults with nondiabetic chronic kidney disease
12 g90 days—
Effects of 24-week prebiotic intervention on self-reported upper respiratory symptoms, gastrointestinal symptoms, and markers of immunity in elite rugby union players
2023 · prebiotic group · Elite rugby union players; age and sex not stated.
2.8 g24 weeks—
Consumption of Extruded Sorghum SC319 Improved Gut Microbiota at Genus Level and Reduced Anthropometric Markers in Men with Overweight: A Randomized Controlled Clinical Trial
2023 · Extruded SC319 whole sorghum · Men aged 18–40 with overweight (BMI 27.0–34.9 kg/m²)
40 g8 weeks—
Cow's milk-based beverage consumption in 1- to 4-year-olds and allergic manifestations: an RCT
2016 · CMBB · Children aged 1 to 4 years attending daycare in Brazil; generally healthy, without a stated diagnosed condition
3.6 g28 weeks125
Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study
2023 · intervention group · Adults aged 18 years or older hospitalized with PCR-confirmed COVID-19 who required more than 48 hours of admission
200 mg—78
Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial
2015 · group S (synbiotics) · Adults undergoing surgery for periampullary neoplasms; age and sex not specified
200 mg2 weeks23
Effectiveness of Sterilized Symbiotic Drink Containing Lactobacillus helveticus Comparable to Probiotic Alone in Patients with Constipation-Predominant Irritable Bowel Syndrome
2020 · Group A (symbiotic group) · Adults with constipation-predominant irritable bowel syndrome; age range not reported; both sexes
5.85 g7 days79
Effect of a Probiotic and a Synbiotic on Body Fat Mass, Body Weight and Traits of Metabolic Syndrome in Individuals with Abdominal Overweight: A Human, Double-Blind, Randomised, Controlled Clinical Study
2023 · Synbiotic · Adults aged 18 years or older, women and men with abdominal overweight or obesity (BMI ≥25 and elevated waist circumference)
10 g12 weeks60
Probiotics combined with prebiotics alleviated seasonal allergic rhinitis by altering the composition and metabolic function of intestinal microbiota: a prospective, randomized, double-blind, placebo-controlled clinical trial
2024 · test group (probiotics and prebiotics) · Adults aged 18–65 with seasonal allergic rhinitis lasting more than 1 year and TNSS greater than 4
60 g90 days53
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial
2023 · Group A · Adults aged 18–70 with functional constipation
7.82 g4 weeks50
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial
2023 · Group B · Adults aged 18–70 with functional constipation
1.48 g4 weeks50
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial
2023 · Group D · Adults aged 18–70 with functional constipation
960 mg4 weeks50
Functional response to a microbial synbiotic in the gastrointestinal system of children: a randomized clinical trial
2023 · Active synbiotic arm · Children aged 3–17, male and female, with variable weekly bowel movement frequency; some had low-frequency bowel movements or constipation
6.2 g12 weeks43
The promising effects of a multi-species synbiotic preparation on metabolic profile in elderly patients with type 2 diabetes and high cardiovascular risk: a randomized, triple-blind, placebo-controlled trial
2025 · Synbiotic group · Men and women aged 65 years or older with type 2 diabetes and high cardiovascular risk
500 mg120 days43
Calorie restriction and synbiotics effect on quality of life and edema reduction in breast cancer-related lymphedema, a clinical trial
2020 · CRS group (calorie-restricted diet plus synbiotic) · Women aged 18–65 with BMI 25–35 and stage I or II breast cancer-related unilateral arm lymphedema
38.5 mg10 weeks41
Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial
2016 · Darmocare Pre® group · Adults aged 66–90 years living in nursing homes; participants were non-demented, able to walk, and aged 65 years or older
3.49 g13 weeks36
Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial
2024 · Prebiotic · Adults aged 63–83 (mean 73), women and men, older healthy volunteers with previously reported low dietary protein intake
7.5 g12 weeks36
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study
2020 · synbiotic group · Female and male adults aged 18–60 with moderate or severe diarrhea-predominant irritable bowel syndrome (IBS-D)
1.89 g8 weeks35
The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial
2023 · Synbiotics · Women aged 18 years or older with breast cancer, no metastasis, undergoing neoadjuvant or adjuvant chemotherapy
42 g8 weeks34
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial
2025 · synbiotic group · Adults aged 60 years or older with functional constipation by Rome IV criteria and no significant comorbidities
800 mg4 weeks34
Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
2023 · synbiotic group · Adults aged 60 years or older with irritable bowel syndrome meeting Rome IV criteria
200 mg4 weeks33
Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson's disease
2025 · synbiotic group · Adults aged 45–65, both sexes, newly diagnosed with Parkinson's disease, stages 1–4
6 g90 days33
A synbiotic mixture for the management of infantile colic: A randomized trial
2024 · Group 2 (two doses of the synbiotic combination) · Full-term, presumed healthy infants aged 2–8 weeks with symptoms suggesting infantile colic; all feeding types were allowed.
40 mg4 weeks31
Preliminary clinical study on the synergistic effects of prebiotics and β-hydroxy-β-methylbutyrate in improving muscle function and intestinal barrier function in elderly patients with sarcopenia
2026 · Group B · Adults aged 65 years or older with sarcopenia
10 g30 days31
The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial
2023 · Synbiotic group · Adults aged 25–65, women and men with subclinical hypothyroidism treated with levothyroxine
500 mg10 weeks28
Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis
2016 · synbiotic group · Adults aged 25–74 with biopsy-confirmed nonalcoholic steatohepatitis (NASH); both sexes
8 g90 days27
Effects of synbiotic supplementation on the components of metabolic syndrome in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
2024 · Synbiotic + antipsychotic group · Adults aged 18–65 with schizophrenia, BMI ≥23 and at least two metabolic-syndrome criteria, taking antipsychotic drugs
42 mg8 weeks27
Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation
2014 · Treatment Group (TG) · Adults aged 18–45 years, both sexes, with chronic constipation
3.6 g2 weeks26
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study
2025 · 2FL + PA + BA · Adults aged 18–90 with a diagnosed primary Parkinsonian syndrome and moderate disease severity
3.9 g26 weeks24
Effects of probiotic and synbiotic supplementation on ponderal and linear growth in severely malnourished young infants in a randomized clinical trial
2023 · Synbiotic · Infants aged 2–6 months with severe acute malnutrition, recovering from acute illness; both sexes
3.2 g4 weeks23
Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial
2023 · L-carnitine + synbiotic · Women aged 19–49 with obesity (BMI 30–35 kg/m²), without the listed comorbidities
175 mg8 weeks23
Do synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults?: Randomized, double-blind, placebo-controlled trial
2022 · Synbiotics · Healthy adults aged 20–60 years, men and women, with bowel movements 2–3 times per week and a tendency to constipation
1 g2 weeks22
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal Calprotectin Levels: A Pilot Study
2022 · synbiotic group · Adults with functional diarrhea and fecal calprotectin levels of at least 11.5 mg/kg; mean age 49.8 years
2.4 g8 weeks20
Agave tequilana Fructans Versus Psyllium plantago for Functional Constipation : Randomized Double-blind Clinical Trial
2024 · Group 3: AF 5 g (Predilife)+10 g maltodextrin (MTDx) · Adults with functional constipation; age and sex range not reported
5 g8 weeks20
Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study
2011 · synbiotics treatment group · Patients with mild to moderate ulcerative colitis
5.5 g1 year—
Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study
2014 · XOS+Bi-07 synbiotic · Healthy adults aged 25–65 years
8 g3 weeks—
Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial
2016 · LU + B420 · Adults aged 18–65 with overweight or obesity (BMI 28.0–34.9)
12 g26 weeks—
Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial
2019 · oligofructose · Individuals with liver-biopsy-confirmed NASH and NAS ≥ 5; age and sex not reported
24 g36 weeks—
Effect of Bacillius Coagulans and Galactomannans on Obese Patients Undergoing Sleeve Gastrectomy, A Randomized-Controlled Clinical Trial
2021 · LactoWise® group (LWG) · Morbidly obese patients undergoing laparoscopic sleeve gastrectomy; age and sex not specified
300 mg90 days—
Effect of synbiotic and probiotic supplementation on serum brain-derived neurotrophic factor level, depression and anxiety symptoms in hemodialysis patients: a randomized, double-blinded, clinical trial
2021 · synbiotic · Hemodialysis patients; age and sex not specified
15 g12 weeks—
Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial
2023 · synbiotic supplementation group (SG) · Overweight and obese Hong Kong Chinese individuals aged 20–65 years
3.4 g8 weeks—
Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial
2023 · dietary intervention with synbiotic supplementation group (DSG) · Overweight and obese Hong Kong Chinese individuals aged 20–65 years
3.4 g8 weeks—
Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial
2024 · treatment arm · People diagnosed with pre-diabetes who were not receiving glucose-lowering medications; age and sex not reported
20 g24 weeks33
Is there any place for resistant starch, as alimentary prebiotic, for patients with type 2 diabetes?
2015 · intervention · Women with type 2 diabetes
10 g8 weeks28
Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods
2012 · Soy foods with prebiotic · Hypercholesterolemic men and postmenopausal women
10 g30 days—
The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial
2019 · prebiotic group · Women aged 18–45 with polycystic ovary syndrome
20 g90 days—
Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial
2023 · Group C · Adults aged 18–70 with functional constipation
3.8 g4 weeks50
Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial
2024 · synbiotic group · Women aged 18–45 with newly diagnosed polycystic ovary syndrome (PCOS)
500 mg12 weeks28
Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study
2019 · Prebiotic group · Adults aged 18–60 with mild constipation
13 g4 weeks20
Effects of a Synbiotic Formula on Functional Bowel Disorders and Gut Microbiota Profile during Long-Term Home Enteral Nutrition (LTHEN): A Pilot Study
2020 · intervention group (IG) · Bedridden adults with neurological disorders receiving long-term home enteral nutrition; average age 75.2 years
375 mg120 days11
Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sedentary Individuals after Consuming a Synbiotic. A Triple-Blinded, Randomized, Placebo-Controlled Pilot Study
2021 · Sedentary participants administered with the synbiotic · Sedentary male students with low physical activity (≤150 min/week)
200 mg30 days—
Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sedentary Individuals after Consuming a Synbiotic. A Triple-Blinded, Randomized, Placebo-Controlled Pilot Study
2021 · Professional soccer players administered with the synbiotic · Male professional soccer players competing in the Spanish Second Division B
200 mg30 days—
A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women
2025 · SBD111 · Healthy postmenopausal women 1–6 years after menopause, aged about 55 years; some had osteopenia or BMI ≥30
1.28 g1 year144
The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared With Rice: A Randomized, Controlled Trial
2021 · oat group · Adults aged 18–65 with mild hypercholesterolemia
80 g45 days94
Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients
2019 · prebiotic group · Men and women aged 40–75 years with colorectal cancer undergoing perioperative care
30 g7 days70
Lactulose ingestion causes an increase in the abundance of gut-resident bifidobacteria in Japanese women: a randomised, double-blind, placebo-controlled crossover trial
2021 · lactulose ingestion · Japanese women; age and health condition not specified
2 g2 weeks60
Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal
2012 · AXOS 2.2 g/d · Healthy men and women; ages not specified
2.2 g3 weeks55
Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal
2012 · AXOS 4.8 g/d · Healthy men and women; ages not specified
4.8 g3 weeks55
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention
2024 · prebiotics · Adult men and women with obesity; age range not reported
16 g90 days51
Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress
2021 · Biotis™ GOS · 20 prefrail elderly adults and 24 healthy adults
15 g4 weeks44
Differential effects of inulin and fructooligosaccharides on gut microbiota composition and glycemic metabolism in overweight/obese and healthy individuals: a randomized, double-blind clinical trial
2025 · FOS group · Chinese adults with normal weight or overweight/obesity; adults with overweight/obesity were included alongside healthy normal-weight controls
15 g4 weeks43
A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers
2012 · AXOS-bread · Healthy adults aged 18–55 years, without chronic disease
2.2 g3 weeks40
Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons
2015 · B-GOS · Volunteers aged 65–80 years
5.5 g10 weeks40
A Randomized, Double-Blind, Placebo-Controlled Trial: Efficacy of Opuntia ficus-indica Prebiotic Supplementation in Subjects with Gut Dysbiosis
2024 · Group A (active treatment arm) · Healthy males and females aged 25–50 with gut dysbiosis of unknown etiology
300 mg8 weeks40
Effects of a diverse prebiotic fibre blend on inflammation, the gut microbiota and affective symptoms in metabolic syndrome: a pilot open-label randomised controlled trial
2024 · Treatment group · Males and females aged 18–75 years who met criteria for metabolic syndrome
10 g12 weeks40
Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month
2017 · FOS intake group · Healthy pregnant women; ages and sex beyond pregnancy status not reported
8 g—35
Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population
2017 · GOS group · Adults aged 18–65 years, both sexes, described as healthy
16 g2 weeks35
Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial
2020 · inulin-type fructans · Adult men and women with type 2 diabetes
16 g6 weeks35
Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population
2017 · FOS group · Adults aged 18–65 years, both sexes, described as healthy
16 g2 weeks34
Consumption of Galacto-Oligosaccharides Increases Iron Absorption from Ferrous Fumarate: A Stable Iron Isotope Study in Iron-Depleted Young Women
2019 · Daily GOS consumption · Iron-depleted young women
15 g4 weeks34
Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial
2020 · intervention · Adult women with type 2 diabetes mellitus
10 g8 weeks33
Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial
2020 · intervention · Adult women with type 2 diabetes mellitus
10 g8 weeks33
β2-1 Fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults
2016 · β2-1 fructan · Healthy adult men and women
15 g4 weeks30
Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial
2015 · intervention group · Women with type 2 diabetes
10 g8 weeks30
A randomized controlled trial on the efficacy of resistant dextrin, as functional food, in women with type 2 diabetes: Targeting the hypothalamic-pituitary-adrenal axis and immune system
2018 · intervention group · Women with type 2 diabetes mellitus
10 g8 weeks30
The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial
2022 · intervention group · Adults over 18 with stage 3–5 chronic kidney disease attending a predialysis clinic; predominantly female
13.5 g14 weeks30
A human milk oligosaccharide alters the microbiome, circulating hormones, and metabolites in a randomized controlled trial of older adults
2025 · Low Dose 2′-FL arm · Healthy adults aged 60–83.9 years, both sexes
1 g6 weeks30
Effects of wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal parameters in healthy preadolescent children
2014 · WBE 5.0 g/day · Healthy children aged 8–12 years
5 g3 weeks29
A human milk oligosaccharide alters the microbiome, circulating hormones, and metabolites in a randomized controlled trial of older adults
2025 · High Dose 2′-FL arm · Healthy adults aged 60–83.9 years, both sexes
5 g6 weeks29
Consumption of Solnul(™) Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial
2023 · Low dose (3.5 g RPS combined with 3.5 g digestible corn starch) · Healthy adults aged 18–69 years
3.5 g4 weeks25
Consumption of Solnul(™) Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial
2023 · High dose (7 g RPS) · Healthy adults aged 18–69 years
7 g4 weeks25
Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial
2023 · OF · Adults aged 18–50, men and women, with mild-to-moderately elevated stress and anxiety
8 g4 weeks24
Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial
2023 · 2’FL · Adults aged 18–50, men and women, with mild-to-moderately elevated stress and anxiety
2 g4 weeks24
β2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial
2012 · β2-1 fructans (Orafti® Synergy1) · Healthy adults aged 45–65 years
8 g4 weeks22
Relative abundance of the Prevotella genus within the human gut microbiota of elderly volunteers determines the inter-individual responses to dietary supplementation with wheat bran arabinoxylan-oligosaccharides
2020 · Wheat bran AXOS supplement · Men and women aged 60 years and above, BMI 20–32 kg/m², free-living elderly volunteers
15 g10 days21
Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis
2011 · GBF group · Patients with ulcerative colitis in remission
30 g60 days20
Wheat bran extract alters colonic fermentation and microbial composition, but does not affect faecal water toxicity: a randomised controlled trial in healthy subjects
2015 · WBE · Healthy subjects
10 g3 weeks20
Oligofructose decreases serum lipopolysaccharide and plasminogen activator inhibitor-1 in adults with overweight/obesity
2017 · oligofructose · Adults with overweight or obesity
21 g12 weeks20
Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts
2021 · kestose group · Healthy men and women aged 20–64 years with BMI ≥23 kg/m², mostly overweight or obese; participants with treated diabetes and specified abnormal metabolic measures were excluded.
10 g12 weeks20
A low-dose prebiotic fiber supplement reduces lipopolysaccharide-binding protein concentrations in a subgroup of young, healthy adults consuming low-fiber diets
2025 · prebiotic fiber mix · Healthy adults aged 18–45 years, men and women, BMI 23–32 kg/m², habitually consuming less than 15 g fiber per day
12 g4 weeks20
Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women
2015 · Flaxseed mucilage · Women aged 40–70 years, postmenopausal for at least 1 year, with obesity (BMI 30–45 kg/m²)
10 g6 weeks19
Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders
2018 · prebiotic group · Patients with functional gastrointestinal disorders and flatulence; age and sex not reported
2.8 g4 weeks19
2'-Fucosyllactose supplementation results in a transient improvement in gut microbial resilience after vancomycin use in adults with overweight or obesity: a randomized, double-blind, placebo-controlled intervention
2025 · 2′-FL group · Adults aged 20–65 years with overweight or obesity (BMI 25–40 kg/m²), without impaired fasting glucose or impaired glucose tolerance
12 g8 weeks18
Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier
2018 · 15 g/d AX · Overweight and obese subjects
15 g6 weeks17
Reversible aberrancies in gut microbiome of moderate and late preterm infants: results from a randomized, controlled trial
2023 · Preterm Prebiotic · Moderate and late preterm neonates born at 32+0 to 36+6 weeks’ gestation, birth weight greater than 1500 g, enrolled at 1–3 days old
600 mg60 days17
Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier
2018 · 7.5 g/d AX · Overweight and obese subjects
7.5 g6 weeks16
Effects of 1-kestose on microbiome changes caused by vonoprazan: a randomized, double-blind, placebo-controlled pilot study
2024 · 1-kestose group · Patients scheduled to undergo endoscopic resection for superficial gastroduodenal tumors
10 g8 weeks16
A prebiotic intervention study in children with autism spectrum disorders (ASDs)
2018 · B-GOS® group · Children aged 4–11 years with diagnosed autism spectrum disorder; some followed an exclusion diet and others an unrestricted diet
1.8 g6 weeks13
Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
2016 · 2′FL 5 g · Healthy adults aged 18–60 years, male and female
5 g2 weeks10
Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
2016 · 2′FL 10 g · Healthy adults aged 18–60 years, male and female
10 g2 weeks10
Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
2016 · 2′FL 20 g · Healthy adults aged 18–60 years, male and female
20 g2 weeks10
Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
2016 · LNnT 5 g · Healthy adults aged 18–60 years, male and female
5 g2 weeks10
Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
2016 · LNnT 10 g · Healthy adults aged 18–60 years, male and female
10 g2 weeks10
Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota
2016 · LNnT 20 g · Healthy adults aged 18–60 years, male and female
20 g2 weeks10
The in vivo use of the stable isotope-labelled biomarkers lactose-[15N]ureide and [2H4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers
2004 · prebiotic · Healthy human volunteers; age and sex not stated
20 g2 weeks9
Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment
2014 · GOS · Healthy adults aged 18–45 years with normal BMI receiving amoxicillin treatment
7.5 g12 days6
Time-Restricted Eating and Prebiotic Supplementation Demonstrate Feasibility and Acceptability in Young Adult Pediatric Cancer Survivors: A Randomized Controlled Pilot Trial
2025 · 8-h TRE plus prebiotic supplement (PreTRE) · Young adults aged 18–39 who had completed treatment for pediatric cancer and had overweight or obesity
2.75 g12 weeks6
Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial
2012 · group III: the prebiotic · Adults aged 18–65 with HIV infection, antiretroviral-treatment-naïve, CDC stage A or B, and CD4+ count >350 cells/mm³
10 g16 weeks5
Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans
2004 · lactulose group · Healthy volunteers; age and sex not reported
10 g6 weeks—
Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial
2006 · GOS/FOS group · Fully formula-fed infants aged 4 to 6 months starting solid foods
4.5 g6 weeks—
Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology
2007 · 0:10 sucrose:lactitol group · healthy, non-adapted adults; age and sex not specified
10 g7 days—
Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity--a randomized, double-blind, placebo-controlled study
2007 · GOS/lcFOS group · Pregnant women receiving supplementation from week 25 of gestation until delivery
9 g——
Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study
2008 · Commercial galactooligosaccharide, 7 g/d · Healthy human volunteers; age and sex not reported
7 g7 days—
Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study
2008 · Novel galactooligosaccharide, 3.6 g/d · Healthy human volunteers; age and sex not reported
3.6 g7 days—
Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study
2008 · Novel galactooligosaccharide, 7 g/d · Healthy human volunteers; age and sex not reported
7 g7 days—
A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans
2008 · 15 g resistant maltodextrin · Healthy adult humans
15 g3 weeks—
Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers
2008 · B-GOS treatment · Healthy elderly volunteers; age range and sex not specified
5.5 g10 weeks—
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome
2009 · 3.5 g/d prebiotic · Patients with Rome II positive irritable bowel syndrome
3.5 g12 weeks—
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome
2009 · 7 g/d prebiotic · Patients with Rome II positive irritable bowel syndrome
7 g12 weeks—
Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal
2009 · prebiotic group · Healthy adult men and women
16 g2 weeks—
Determination of the in vivo prebiotic potential of a maize-based whole grain breakfast cereal: a human feeding study
2010 · WGM cereal · Healthy men and women, mean age 32 years
48 g3 weeks—
The effect of pre- and probiotics on the colonic ammonia metabolism in humans as measured by lactose-[¹⁵N₂]ureide
2010 · wrinkle pea starch (WPS) · Healthy adults aged 20–28 years
30 g10 days—
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial
2011 · 15 g/day prebiotic group · HAART-naive adults with HIV-1 infection; age and sex not specified
15 g12 weeks—
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial
2011 · 30 g/day prebiotic group · HAART-naive adults with HIV-1 infection; age and sex not specified
30 g12 weeks—
A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age
2012 · GOS · Men and women aged 50 years and above
8 g3 weeks—
Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects
2012 · polydextrose (PDX) · healthy human subjects
8 g——
Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties
2012 · XOS · Healthy volunteers
5 g4 weeks—
Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers
2012 · WR(+) bread · Healthy volunteers; age and sex not specified
2.14 g3 weeks—
Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial
2013 · 2·5 g GOS group · Healthy girls aged 10–13 years
5 g3 weeks—
Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial
2013 · 5 g GOS group · Healthy girls aged 10–13 years
10 g3 weeks—
Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota
2014 · 1.4 g XOS group · Healthy adult subjects
1.4 g8 weeks—
Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota
2014 · 2.8 g XOS group · Healthy adult subjects
2.8 g8 weeks—
[A machine learning model based on initial gut microbiome data for predicting changes of Bifidobacterium after prebiotics consumption]
2018 · FOS group · Healthy volunteers; age and sex not reported
16 g9 days—
[A machine learning model based on initial gut microbiome data for predicting changes of Bifidobacterium after prebiotics consumption]
2018 · GOS group · Healthy volunteers; age and sex not reported
16 g9 days—
Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial
2019 · prebiotic (FOS) group · Adults aged 18–80 years with nondiabetic non-dialysis-dependent chronic kidney disease and eGFR <45 mL/min/1.73 m²
12 g90 days—
Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics
2018 · GOS · Women and men aged 18–65 years with obesity (BMI 30.0–40.0 kg/m²)
5 g3 weeks—
Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial
2018 · resistant starch · Adults receiving hemodialysis with chronic kidney disease; age and sex not reported
8 g4 weeks—
Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults
2019 · Litesse® Ultra™ polydextrose (LU) · Overweight or obese adults
12 g26 weeks—
A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
2019 · D1 · Healthy adults aged 18–55 years
2.5 g90 days—
A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
2019 · D2 · Healthy adults aged 18–55 years
5 g90 days—
A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
2019 · D3 · Healthy adults aged 18–55 years
10 g90 days—
Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study
2020 · RS group · Adults with chronic kidney disease receiving hemodialysis; mean age 55.3 years; 56% men
16 g4 weeks—
Prebiotic potencial of juçara berry on changes in gut bacteria and acetate of individuals with obesity
2020 · juçara group · Adults aged 31–59 years, both sexes, with obesity classes I and II
5 g6 weeks—
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial
2021 · YBG · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors
500 mg5 weeks—
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial
2021 · SBG · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors
500 mg5 weeks—
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial
2021 · OBG · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors
10 g5 weeks—
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial
2021 · AX · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors
10 g5 weeks—
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial
2021 · EPS · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors
2.3 g5 weeks—
Decreased Gut Microbiome Tryptophan Metabolism and Serotonergic Signaling in Patients With Persistent Mental Health and Gastrointestinal Symptoms After COVID-19
2022 · low-dose inulin · Adults aged 18 years or older hospitalized with moderate COVID-19, free from chronic GI symptoms at baseline, and given broad-spectrum antibiotics
16 g7 days—
Decreased Gut Microbiome Tryptophan Metabolism and Serotonergic Signaling in Patients With Persistent Mental Health and Gastrointestinal Symptoms After COVID-19
2022 · high-dose inulin · Adults aged 18 years or older hospitalized with moderate COVID-19, free from chronic GI symptoms at baseline, and given broad-spectrum antibiotics
32 g7 days—
Effects of dragon fruit oligosaccharides on immunity, gut microbiome, and their metabolites in healthy adults - A randomized double-blind placebo controlled study
2023 · 4 g/day DFO group · Healthy adults
4 g4 weeks—
Effects of dragon fruit oligosaccharides on immunity, gut microbiome, and their metabolites in healthy adults - A randomized double-blind placebo controlled study
2023 · 8 g/day DFO group · Healthy adults
8 g4 weeks—
Maternal prebiotic supplementation during pregnancy and lactation modifies the microbiome and short chain fatty acid profile of both mother and infant
2024 · prebiotic group · Pregnant women who continued supplementation during lactation; their infants were also assessed
14.2 g——
The Effects of Prebiotic Supplementation on Markers of Exercise-Induced Gastrointestinal Syndrome in Response to Exertional Heat Stress
2025 · PREBIOTIC · Endurance athletes; age and sex not reported
16 g8 weeks—
Iron absorption and loss, and efficacy of iron supplementation with and without prebiotics in children with virally suppressed HIV: three prospective studies in South Africa
2025 · iron + GOS · children aged 10–15 years with virally suppressed HIV and iron deficiency
7.5 g12 weeks42
Maternal Human Milk Oligosaccharide Profile Modulates the Impact of an Intervention with Iron and Galacto-Oligosaccharides in Kenyan Infants
2019 · FeGOS group · Generally healthy infants aged 6.5–9.5 months; no stated diagnosed condition
10.5 g120 days25
Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants
2024 · 7.5-g+iron group · Kenyan infants
7.5 g3 weeks—
Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants
2024 · 3-g+iron group · Kenyan infants
3 g3 weeks—
Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
2018 · sitagliptin-synbiotic group (group 2) · Adults aged 18–60 with nonalcoholic fatty liver disease, BMI 25–29.9, and impaired fasting glucose and/or impaired glucose tolerance
500 mg16 weeks70
Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple-Blind, Placebo-Controlled Trial
2022 · synbiotic · Adults with metabolic syndrome; age range and sex distribution not specified
77 g12 weeks65
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease
2020 · synbiotic treatment · Adults with proven nonalcoholic fatty liver disease (NAFLD); ages and sex distribution not specified for this arm
8 g1 year55
Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial
2023 · Synbiotic · Healthy adults aged 18–65 years; 66% female in this arm; no stated disease
500 mg8 weeks53
Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study
2021 · synbiotic group · Adults aged 30 to under 80 years with obesity and type 2 diabetes mellitus
7.5 g24 weeks45
Yacon syrup reduces postprandial glycemic response to breakfast: A randomized, crossover, double-blind clinical trial
2019 · Intervention B · Adult women, including normal-weight and grade I obese participants
14 g1 day40
Previous gut microbiota has an effect on postprandial insulin response after intervention with yacon syrup as a source of fructooligosaccharides: a randomized, crossover, double-blind clinical trial
2023 · yacon syrup intervention (intervention A) · young adult women
14 g1 day40
The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: a randomized controlled trial
2022 · Synbiotics · Adults over 18 years old with chronic kidney disease on haemodialysis and gastrointestinal complaints including constipation
60 mg60 days30
The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial
2023 · Synbiotic group · Adults aged 25–65, women and men with subclinical hypothyroidism treated with levothyroxine
500 mg10 weeks28
Red Raspberry and Fructo-Oligosaccharide Supplementation, Metabolic Biomarkers, and the Gut Microbiota in Adults with Prediabetes: A Randomized Crossover Clinical Trial
2022 · RRB + FOS · Adults with prediabetes and insulin resistance
8 g4 weeks26
Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial
2023 · OF/2’FL · Adults aged 18–50, men and women, with mild-to-moderately elevated stress and anxiety
10 g4 weeks24
Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial
2022 · synbiotic-supplemented group · Women aged 18–60 with systemic lupus erythematosus and gastrointestinal symptoms
80 mg60 days23
Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial
2014 · synbiotic · Healthy volunteers; age and sex not reported.
5 g3 weeks18
Double blind randomized clinical trial controlled by placebo with an alpha linoleic acid and prebiotic enriched cookie on risk cardiovascular factor in obese patients
2011 · Group I (inulin, FOS and ALA enriched cookie) · Obese patients; age and sex not specified
3.1 g30 days15
Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection
2012 · Synbiotic · Adult women with HIV-1 infection taking antiretroviral medication and with blood CD4 count >200 cells/μl
2.5 g4 weeks14
Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection
2012 · Fiber-only · Adult women with HIV-1 infection taking antiretroviral medication and with blood CD4 count >200 cells/μl
2.5 g4 weeks13
Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity
2020 · synbiotic (treatment) group · Adult men and women, mean age 47.4 years, initially overweight or obese (mean BMI 33.5 kg/m²), enrolled in a weight-loss program; participants with gastrointestinal, autoimmune or metabolic diseases and relevant medications were excluded.
5.5 g90 days10
Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2)
2020 · Synbiotic NATUREN G · Adults aged 30–65 with stage V chronic kidney disease receiving hemodialysis
10 g8 weeks7
Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial
2012 · group II: the synbiotic · Adults aged 18–65 with HIV infection, antiretroviral-treatment-naïve, CDC stage A or B, and CD4+ count >350 cells/mm³
10 g16 weeks5
In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own
2008 · LGG plus GOS · Healthy school-aged children
2 g3 weeks—
A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans
2008 · 7.5 g maltodextrin plus 7.5 g resistant maltodextrin · Healthy adult humans
7.5 g3 weeks—
Impact of a jelly containing short-chain fructo-oligosaccharides and Sideritis euboea extract on human faecal microbiota
2009 · sc-FOS+extract group · Healthy volunteers aged 22–51, men and women, with no stated condition
5 g30 days—
Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol
2012 · synbiotic dietary supplement · healthy elderly volunteers
10 g2 weeks—
Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties
2012 · INU-XOS · Healthy volunteers
1 g4 weeks—
Freeze-dried powdered yacon: effects of FOS on serum glucose, lipids and intestinal transit in the elderly
2014 · supplement group · Elderly men and women, mean age 67.11 ± 6.11 years
7.4 g9 weeks—
An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention
2016 · LAB4 · Recreationally active adults aged about 35 years, 25 men and 5 women in the overall study cohort, training for their first long-distance triathlon
55.8 mg90 days—
Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics
2018 · IVS-1 + GOS · Women and men aged 18–65 years with obesity (BMI 30.0–40.0 kg/m²)
5 g3 weeks—
Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics
2018 · BB-12 + GOS · Women and men aged 18–65 years with obesity (BMI 30.0–40.0 kg/m²)
5 g3 weeks—
Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults
2019 · LU+B420 · Overweight or obese adults
12 g26 weeks—
Plasma and Urinary (Poly)phenolic Profiles after 4-Week Red Raspberry (Rubus idaeus L.) Intake with or without Fructo-Oligosaccharide Supplementation
2020 · RRB+FOS · Men and women aged 20–60 years; participants with prediabetes and insulin resistance and metabolically healthy reference participants
8 g4 weeks—
Multi-species synbiotic supplementation increased fecal short chain fatty acids and anti-inflammatory cytokine interleukin-10 in adult men with dyslipidemia; A randomized, double-blind, clinical trial
2024 · synbiotic group · Adult men with dyslipidemia
10 g12 weeks—
Effects of multi-species synbiotic supplementation on circulating miR-27a, miR-33a levels and lipid parameters in adult men with dyslipidaemia; a randomised, double-blind, placebo-controlled clinical trial
2025 · synbiotic · adult men with dyslipidaemia
10 g12 weeks—
The anti-inflammatory effects of three different dietary supplement interventions
2025 · Synbiotic arm · Adults aged 18 years and older with BMI 20–39.9
10 g6 weeks—
The impact of synbiotic on serum sCD163/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial
2024 · synbiotic group · Adults aged 30–70 with chronic heart failure, LVEF <40%, and NYHA class I–III
38.5 mg10 weeks45
Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial
2024 · Intervention group, H2-SIBO · Adults with diagnosed hydrogen SIBO
5 g90 days32
The association of a probiotic with a prebiotic (Flortec, Bracco) to improve the quality/quantity of spermatozoa in infertile patients with idiopathic oligoasthenoteratospermia: a pilot study
2017 · Flortec group · Men with idiopathic oligoasthenoteratospermia (iAOT) and no chromosomal aberrations
1.94 g26 weeks20
Characterizing gut microbial dysbiosis and exploring the effect of prebiotic fiber supplementation in patients with COPD
2025 · nutritional supplement group · Adults with moderate to very severe, clinically stable COPD (GOLD II–IV); ages reported as 69.3 ± 7.4 years
6 g90 days16
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
2021 · Synbiotic (arm S), CKD patients · Adults aged 30–65 with stage IIIb–IV chronic kidney disease, not on dialysis
5 g60 days13
An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients
2021 · Synbiotic (arm S), healthy volunteers · Healthy adults aged 35–60
5 g60 days12
An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention
2016 · LAB4 ANTI · Recreationally active adults aged about 35 years, 25 men and 5 women in the overall study cohort, training for their first long-distance triathlon
55.8 mg90 days—
Effects of a Synbiotic on Plasma Immune Activity Markers and Short-Chain Fatty Acids in Children and Adults with ADHD-A Randomized Controlled Trial
2023 · Synbiotic 2000 · Children and adults aged 5–55 with ADHD
10 g9 weeks—